Lecture: Doris Taylor – When cell therapy isn’t enough

by Alexey Bersenev on February 25, 2016 · 0 comments

in lectures

Post to Twitter Send Gmail Post to LinkedIn

Professor Doris Taylor is a Director of Center for Cell and Organ Biotechnology at Texas Heart Institute. She is a pioneer of cardiac cell therapy and heart decellularization technique. I’m following her work more than a decade and I’m always inspired by her publications and talks. This talk is the most recent publicly available. It was recorded on February 1 of 2016 at Harvard University.

A teaser
By watching her talk you can learn –

  • Why do cardiac cell therapy trials fail and why we should continue with it
  • Why there is a call from basic scientists to halt cardiac cell therapy trials
  • Why women have superior stem cells
  • Why clinical cardiac cell therapy trials data should be reported by sex
  • What cell population in bone marrow correlates and predicts clinical outcome
  • Why after 16 years of trials we still asking the same questions: what it the right cell, what is the right dose, what is the right delivery
  • How much does it cost to do one experiment on whole decellularized heart
  • Why decellularized patch is a first step for trialing whole bioengineered heart in humans
  • Result of the first attempt for spontaneous in vivo recellularization of heterotopic heart matrix

{ 0 comments… add one now }

Leave a Comment

Previous post:

Next post: